Evidence map›Paper›PMID 42140032›Full record

ArticleTranslational oncology2026

Integrating spatial and single-cell transcriptomics via machine learning to characterize efferocytosis in hepatocellular carcinoma prognosis and immunotherapy.

Qiuyun Yi, Bin Zhou, Xiaohui Gu, Zihui Ma, Bochen Pan, Zhou Yuan, Wen Wen, Chongde Lu

Abstract read
In one paragraph

Article in Translational oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiuyun YiNational Center for Liver Cancer, The Third Affiliated Hospital of Naval Medical University, Shanghai, China; Department of Laboratory Diagnosis, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200438, China.
Bin ZhouDepartment of Hepatic Surgery VI, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), 225 Changhai Road, Shanghai 200433, China.
Xiaohui GuDepartment of General Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 222 Huanhu Xisan Road, Shanghai 201306, China.
Zihui MaDepartment of Hepatic Surgery VI, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), 225 Changhai Road, Shanghai 200433, China.
Bochen PanDepartment of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhou YuanDepartment of General Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 222 Huanhu Xisan Road, Shanghai 201306, China. Electronic address: zhouyuan851@163.com.
Wen WenDepartment of Laboratory Diagnosis, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200438, China. Electronic address: wenwen_smmu@163.com.
Chongde LuDepartment of Hepatic Surgery VI, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), 225 Changhai Road, Shanghai 200433, China. Electronic address: 86246337@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe intratumoral heterogeneity and immunosuppressive microenvironment of hepatocellular carcinoma (HCC) significantly limit therapeutic efficacy. Although efferocytosis is fundamental for tissue homeostasis, its impact on the spatial architecture of the tumor microenvironment (TME) and patient prognosis in HCC remains uncharacterized.

methodsWe integrated single-cell RNA sequencing, spatial transcriptomics, and large-scale bulk datasets to construct an Efferocytosis-Related Scoring System (ERG score). We identified molecular subtypes and traced key cell subsets driving high-efferocytosis features. A robust prognostic model was established via large-scale machine learning screening (101 algorithms) and validated by in vitro experiments (qRT-PCR/Western Blot).

resultsThe ERG score indicates a specific immunosuppressive state driven by the High_ERGs_SPP1_Mac subpopulation. Spatially, this subpopulation physically co-localizes with malignant cells, potentially mediated by the MDK-SDC2 axis. The machine learning-derived risk score serves as a reliable quantitative indicator of High_ERGs_SPP1_Mac abundance, effectively predicting "cold tumor" phenotypes and immune checkpoint upregulation (e.g., PD-1, CTLA4). Additionally, experimental validation confirmed the upregulation of the core gene TPI1 (triosephosphate isomerase 1), aligning with the high glycolytic features of the high-risk subtype.

conclusionThe ERG scoring system offers a novel perspective for deconvoluting HCC heterogeneity. Our findings suggest that SPP1+ macrophages spatially reshape the TME, providing a theoretical basis for optimizing prognostic stratification and personalized immunotherapy.

Indexed as

EfferocytosisHepatocellular carcinomaMachine learningSpatial transcriptomicsSPP1+ macrophagesTPI1

Identifiers

PMID42140032
PMCPMC13199849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.